Stabilization and HPLC Analysis of Betamethasone Sodium Phosphate in Plasma

Journal of Pharmaceutical Sciences

Volumn 93, Issue 3, 2004, Pages 726-732

  Samtani, Mahesh N ^a   Schwab, Matthias ^b   Nathanielsz, Peter W ^c,d   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Department of Obstetrics Gynecology   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Betamethasone sodium phosphate; Corticosteroids; Enzyme inhibitors; HPLC; Pharmacokinetics; Pregnancy; Prodrugs; Sheep; Sodium arsenate; Stability

Indexed keywords

ARSENATE SODIUM; BETAMETHASONE; BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; EDETIC ACID; ENZYME INHIBITOR; STABILIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STABILITY; ENZYME INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; IN VITRO STUDY; ION TRANSPORT; NONHUMAN; PREGNANCY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SHEEP;

EID: 1542724888     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10577     Document Type: Article

References (12)

1. Tsuei SE, Petersen MC, Ashley JJ, McBride WG, Moore RG. 1980. Disposition of synthetic glucocorticoids. II. Dexamethasone in parturient women. Clin Pharmacol Ther 28:88-98.
2. Hare LE, Yeh KC, Ditzler CA, McMahon FG, Duggan DE. 1975. Bioavailability of dexamethasone. II. Dexamethasone phosphate. Clin Pharmacol Ther 18:330-337.
3. Petersen MC, Nation RL, McBride WG, Ashley JJ, Moore RG. 1983. Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 25:643-650.
4. NIH Consensus Development Panel. 1995. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 273:413-418.
5. Jusko WJ, Pyszczynski NA, Bushway MS, D'Ambrosio R, Mis SM. 1994. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J Chromatogr B Biomed Appl 658:47-54.
6. D'Argenio DZ, Schumitzky A. 1997. ADAPT II user's guide: Pharmacokinetic/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource.
7. Tsuei SE, Ashley JJ, Moore RG, McBride WG. 1978. Quantitation of dexamethasone in biological fluids using high-performance liquid chromatography. J Chromatogr A 145:213-220.
8. Rohdewald P, Mollmann H, Barth J, Rehder J, Derendorf H. 1987. Pharmacokinetics of dexamethasone and its phosphate ester. Biopharm Drug Dispos 8:205-212.
9. Derendorf H, Rohdewald P, Hochhaus G, Mollmann H. 1986. HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids. J Pharm Biomed Anal 4:197-206.
10. Szeto HH, Umans JG, Rubinow SI. 1982. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit. Drug Metab Dispos 10:382-386.
11. Mollmann H, Balbach S, Hochhaus G, Barth J, Derendorf H. 1995. Pharmacokinetic-pharmacodynamic correlations of corticosteroids. In: Derendorf H, Hochhaus G, editors. Handbook of pharmacokinetic/pharmacodynamic correlation. Boca Raton, FL: CRC Press, pp 323-361.
12. Van Hoof VO, Deng JT, De Broe ME. 1997. How do plasma membranes reach the circulation? Clin Chim Acta 266:23-31.